New HIV drug for resistant patients
Reuters reports here at the ABC News website: U.S. health officials on Friday approved the use of a new HIV drug, made by Johnson & Johnson, in combination with related therapies to help treat patients who do not first improve with other treatment. The drug, Prezista, is a protease inhibitor designed to treat resistant strains of HIV, the virus that causes AIDS.